Hersteller |
GENWAY
|
Kategorie |
|
Typ |
Antibody |
Specific against |
other |
Menge |
5mg |
Host |
Goat |
ArtNr |
18-511-245392 |
eClass 6.1 |
32160702 |
eClass 9.0 |
32160702 |
Lieferbar |
|
Genway ID: |
GWB-DD8B19 |
Host Animal: |
Goat |
Immunogen: |
Purified human Apolipoprotein AI |
Specificity: |
Apolipoprotein AI (Apo AI) |
Specificity: |
Monospecific by immunoelectrophoresis when tested against normal human serum. |
Type of Product: |
Polyclonal Antibodies to Lipoproteins |
Concentration: |
Total protein: 135 mg/ml (Biuret method) Titer: 2. 7 mg/ml (Becker method)Preservatives: NaN3 |
Buffer: |
20mM Tris pH 7. 4 containing 250mM Sodium chlorideApplications Notes : Specific methodologies have not been tested using this product. |
Warning: |
This product contains sodium azide which has been classified as Xn (Harmful) in European Directive 67/548/EEC in the concentration range of 0. 1â ??1. 0%. When disposing of this reagent through lead or copper plumbing flush with copious volumes of water to prevent azide build-up in drains. Goat anti Apo AI. Goat Antibody to Human Apolipoprotein AI (Apo AI) |
Function: |
Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). |
Subunit: |
Interacts with APOA1BP. |
Subcellular Location: |
Secreted. |
Tissue Specificity: |
Major protein of plasma HDL also found in chylomicrons. Synthesized in the liver and small intestine. |
Ptm: |
Palmitoylated. |
Disease: |
Defects in APOA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). Inheritance is autosomal dominant. |
Disease: |
Defects in APOA1 are a cause of the low HDL levels observed in high density lipoprotein deficiency type 1 (HDLD1) [MIM:205400]; also known as analphalipoproteinemia or Tangier disease (TGD). HDLD1 is a recessive disorder characterized by the absence of plasma HDL accumulation of cholesteryl esters premature coronary artery disease hepatosplenomegaly recurrent peripheral neuropathy and progressive muscle wasting and weakness. In HDLD1 patients ApoA-I fails to associate with HDL probably because of the faulty conversion of pro-ApoA-I molecules into mature chains either due to a defect in the converting enzyme activity or a specific structural defect in Tangier ApoA-I. |
Disease: |
Defects in APOA1 are the cause of amyloid polyneuropathy-nephropathy Iowa type (AMYLIOWA) [MIM:107680]; also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III. AMYLIOWA is a hereditary generalized amyloidosis due to deposition of amyloid mainly constituted by apolipoprotein A1. The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis. Severe peptic ulcer disease can occurr in some and hearing loss is frequent. Cataracts is present in several but vitreous opacities are not observed. |
Disease: |
Defects in APOA1 are a cause of amyloidosis type 8 (AMYL8) [MIM:105200]; also known as systemic non-neuropathic amyloidosis or Ostertag-type amyloidosis. AMYL8 is a hereditary generalized amyloidosis due to deposition of apolipoprotein A1 fibrinogen and lysozyme amyloids. Viscera are particularly affected. There is no involvement of the nervous system. Clinical features include renal amyloidosis resulting in nephrotic syndrome arterial hypertension hepatosplenomegaly cholestasis petechial skin rash. |
Similarity: |
Belongs to the apolipoprotein A1/A4/E family. |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.